The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
8-cyclopentyl-6-hydrazinyl-2-((1-(methylsulfonyl)piperidin-4-yl)amino)pteridin-7(8H)-one ID: ALA5281251
Max Phase: Preclinical
Molecular Formula: C17H26N8O3S
Molecular Weight: 422.52
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CS(=O)(=O)N1CCC(Nc2ncc3nc(NN)c(=O)n(C4CCCC4)c3n2)CC1
Standard InChI: InChI=1S/C17H26N8O3S/c1-29(27,28)24-8-6-11(7-9-24)20-17-19-10-13-15(22-17)25(12-4-2-3-5-12)16(26)14(21-13)23-18/h10-12H,2-9,18H2,1H3,(H,21,23)(H,19,20,22)
Standard InChI Key: XCCCFEGJPRCHRL-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
0.3586 1.0468 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0732 1.4591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7851 1.0472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7851 0.2220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0750 -0.1897 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3586 0.2183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4998 -0.1905 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2144 0.2220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2144 1.0471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4998 1.4598 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9290 -0.1905 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.4998 -1.0157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3559 -0.1942 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0705 0.2183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7851 -0.1942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4998 0.2183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4998 1.0435 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.7851 1.4561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0705 1.0435 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2144 1.4561 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-3.9290 1.0435 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8010 2.1721 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.6270 2.1721 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9290 1.4598 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9290 2.2849 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1670 -1.5004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9122 -2.2849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0873 -2.2849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8325 -1.5004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 2 0
1 6 1 0
4 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
3 10 1 0
8 11 2 0
12 7 1 0
6 13 1 0
13 14 1 0
15 14 1 0
16 15 1 0
17 16 1 0
18 17 1 0
19 18 1 0
14 19 1 0
17 20 1 0
20 21 1 0
20 22 2 0
20 23 2 0
9 24 1 0
24 25 1 0
26 12 1 0
26 27 1 0
27 28 1 0
28 29 1 0
29 12 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 422.52Molecular Weight (Monoisotopic): 422.1849AlogP: 0.42#Rotatable Bonds: 5Polar Surface Area: 148.13Molecular Species: NEUTRALHBA: 10HBD: 3#RO5 Violations: ┄HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 4.65CX LogP: -1.06CX LogD: -1.06Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.46Np Likeness Score: -1.59
References 1. Wang X, Ding L, Jiang H, Yuan X, Xiang L, Tang C.. (2023) Synthesis and biological evaluation of novel pteridin-7(8H)-one derivatives as potent CDK2 inhibitors., 88 [PMID:37060933 ] [10.1016/j.bmcl.2023.129284 ]